carmustine has been researched along with Nephritis in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Nephritis: Inflammation of any part of the KIDNEY.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moulder, JE | 1 |
Fish, BL | 1 |
1 other study available for carmustine and Nephritis
Article | Year |
---|---|
Influence of nephrotoxic drugs on the late renal toxicity associated with bone marrow transplant conditioning regimens.
Topics: Animals; Antineoplastic Agents; Blood Urea Nitrogen; Bone Marrow Transplantation; Carmustine; Cispla | 1991 |